A Study to Evaluate Imetelstat (JNJ-63935937) in Transfusion-Dependent subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) that is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Janssen Research & Development, LLC
Start Date
July 1, 2016
End Date
August 28, 2018
Administered By
Duke Cancer Institute
Awarded By
Janssen Research & Development, LLC
Start Date
July 1, 2016
End Date
August 28, 2018